BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Ebola outbreak
Hantavirus
Trump administration impacts
Med-tech outlook 2026
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Wednesday, June 3, 2026
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Aug. 30, 2007
View Archived Issues
New treatments for autoimmune diseases and immunological disorders divulged in recent patents
Read More
SVT-40776 increases voiding volume in healthy postmenopausal women
Read More
Eculizumab reduces thromboembolism risk in paroxysmal nocturnal hemoglobinuria
Read More
Recent OSI and Shanghai Hengrui patents impart new therapeutic agents for cancer
Read More
Recent Tecnogen patent describes novel treatment options for arthritis
Read More
Recent Roche patents disclose new antidepressant agents
Read More
IDEAL extension reveals long-term safety of rivastigmine patch in Alzheimer's disease
Read More
In vivo efficacy of BMS-687453, a novel PPARalpha agonist, disclosed by BMS
Read More
E.U. approves new formulation of Rebif for relapsing MS
Read More
Colorectal cancer target may be discontinued based on unfavorable data with matuzumab
Read More
Adolor moving closer to possible lift of FDA clinical hold on alvimopan for POI
Read More
FDA accepts Schering-Plough/Merck NDA for loratadine/montelukast tablet
Read More
MGI Pharma gains rights to thrombopoietin mimetic from AkaRx
Read More
Bronchitol demonstrates efficacy in phase III bronchiectasis trial
Read More
Biomira initiates phase I trial of PX-478 in patients with advanced metastatic cancers
Read More
HGS completes patient enrollment in phase III Albuferon trial
Read More
Once-daily Seroquel XR approved in the Netherlands for schizophrenia
Read More
ALS-357 granted FDA orphan drug designation for metastatic melanoma
Read More
BioLineRx Inlicenses acute kidney injury treatment
Read More
Inflazyme will not exercise option with Helicon to buy back IPL-455903
Read More
Enrollment complete for phase III trial of Zingo in adults
Read More
PDL BioPharma announces changes to focus on antibody R&D
Read More
Fast track status granted to Pharmion's oral azacitidine for MDS
Read More
Phase II pediatric clinical evaluation of intravenous artesunate for severe malaria commences
Read More
